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 Mechanoreceptors, chemoreceptors, and awareness of motor output continuously convey information 
about breathing to the cerebral cortex and contribute 
to producing a variety of specifi c sensory perceptions. 1 
Perceived threats to respiratory homeostasis are unpleas-
 Background:  Most measures of dyspnea assess a single aspect (intensity or distress) of the symptom. 
We developed the Multidimensional Dyspnea Profi le (MDP) to measure qualities and intensities 
of the sensory dimension and components of the affective dimension. The MDP is not indexed to 
a particular activity and can be applied at rest, during exertion, or during clinical care. We report 
on the development and testing of the MDP in patients with a variety of acute and chronic cardio-
pulmonary conditions. 
 Methods:  One hundred fi fty-one adults admitted to the ED with breathing symptoms completed 
the MDP three times in the ED, twice at least 1 h apart (T1, T2), and near discharge from 
the ED (T3). Measures were repeated in 68 patients twice in a follow-up session 4 to 6 weeks 
later (T4-T5). The ED sample was 56% men with a mean age of 53   15 years; the follow-up 
sample was similar. 
 Results:  Factor analysis resulted in a two-factor solution with a total explained variance of 63%, 74%, 
and 72% at T1, T2, and T3, respectively. One domain related to primary sensory qualities and 
immediate unpleasantness, and the second encompassed emotional response. For the two domains, 
Cronbach  a ranged from 0.82 to 0.95, and the intraclass correlation coeffi cient ranged from 0.91 
to 0.98. Repeated-measures analysis was signifi cant for change (T1, T3, T4), showing responsiveness 
to change in MDP domains with treatment ( F [2,66]   5 19.67,  P  . .001). 
 Conclusions:  These analyses support the reliability, validity, and responsiveness to clinical change 
of the MDP with two domains in an acute care and follow-up setting. 
  CHEST 2012; 141(6):1546–1553 
 Abbreviations: BSI  5 Brief Symptom Inventory; ICC  5 intraclass correlation coeffi cient; MDP  5 Multidimensional 
Dyspnea Profi le; MMSE  5 Mini-Mental State Examination; MRC  5 Medical Research Council; PFSDQ-M  5 modifi ed 
Pulmonary Function Status Dyspnea Questionnaire 
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ant and are accompanied by emotional responses. 2 
Dyspnea has been defi ned as “a subjective experience 
of breathing discomfort that consists of qualitatively 
distinct sensations that vary in intensity,” and the expe-
rience “derives from interactions among multiple 
physiologic, psychologic, social, and environmental 
fac tors.” 1 Although this defi nition recognizes the com-
plexity of dyspnea perception, commonly used dyspnea 
mea sures do not adequately assess this complexity. 
 Correspondence to: Paula M. Meek, RN, PhD, College of 
Nursing, University of Colorado - Denver, 13120 E 19th Ave, 
Aurora, CO 80045; e-mail: Paula.meek@ucdenver.edu 
 © 2012 American College of Chest Physicians. Reproduction 
of this article is prohibited without written permission from the 
American College of Chest Physicians. See online for more details. 
 DOI: 10.1378/chest.11-1087 
www.chestpubs.org CHEST / 141 / 6 / JUNE, 2012  1547 
 Materials and Methods 
 Instrument Development and Content Validity 
 The MDP was developed from existing instruments for pain 
and dyspnea and subsequently refi ned through laboratory work. 14 
It comprises 12 items ( Fig 1 ): an immediate sensory intensity 
item, an immediate unpleasantness item, fi ve items addressing 
sensory qualities (eg, tightness, muscle work), and fi ve emotional 
response items (eg, frustration, anxiety). Sensory qualities of dys-
pnea were reduced from a list of 19 descriptors 8 to fi ve descrip-
tor groups based on previous factor analysis in patients 26,27 and 
laboratory use in healthy subjects and patients. The emotional 
response items were adapted from pain research. 28,29 
 All items were measured on a rating scale of 0 to 10, with higher 
scores indicating greater intensity, unpleasantness, or distress. For 
overall intensity and unpleasantness, scaling words were used that 
accorded with the aspect being rated (ie, none, moderate, maximum, 
overall intensity vs neutral, annoying, unbearable unpleasantness). 
For the sensory quality items, subjects rated the intensity of 
the fi ve descriptors, with 0 signifying “does not apply” and 10 signi-
fying “as intense as I can imagine.” Subjects were instructed to 
rate each emotional response item on a scale labeled “none” to the 
“most severe imaginable.” See e-Appendix 1 for a detail script for 
fi rst-time use. 
 This investigation used a longitudinal design that allowed serial 
determination of internal consistency, temporal stability, and 
responsiveness of the MDP to clinical change over time. We 
recruited individuals presenting to the ED with a breathing com-
plaint. Patients with acute coronary syndromes or malignant neo-
plasms of the head, neck, thorax, or abdomen were excluded. The 
study had ethical approval from the University of New Mexico 
Human Research Review Committee (HRRC #07-062). 
 Dyspnea research is currently hampered by the 
lack of a single instrument to measure different aspects 
of respiratory discomfort in a variety of settings. A 
number of clinical dyspnea instruments provide indi-
rect measurement of several aspects of patients’ expe-
rience of dyspnea. 3,4 Most clinical questionnaires rely 
on patient recall to assess daily activities and do 
not directly scale sensation. Single-dimension scales 
(eg, visual analog, Borg, number) are widely used to 
measure dyspnea, especially in experimental settings. 4,5 
The rating of the perceptual dimension often is poorly 
defi ned in published reports, 6 and the meaning can 
vary across studies (eg, a laboratory subject breath-
ing against a resistive load and rating the intensity of 
effort, a patient in an ED rating emotional distress). 
Specifi cally, the original descriptor list developed by 
Simon et al 7,8 has been used by several investigators 
in the exploration of how individuals would describe 
breathlessness in various conditions and settings. 9-11 
However, others have modifi ed the list such that com-
parison across investigations is diffi cult. 12,13 
 The Multidimensional Dyspnea Profi le (MDP) is a 
comprehensive instrument designed to measure sen-
sory and affective dimensions of dyspnea. The con-
ceptual model we proposed for dyspnea asserts that 
each item in the MDP has the potential to vary sepa-
rately from the others under some circumstances. 14 
Our approach in developing this instrument was 
based on the multidimensional model of pain. 15-20 
Intensity (strength of sensation), quality, unpleasant-
ness, and emotion are distinct aspects of pain percep-
tion, with evidence accumulating that these dimensions 
are also relevant to dyspnea perception. 8,13,14,21-23 
Advances in the ability to understand and measure 
the several dimensions of dyspnea could facilitate 
comparison of different laboratory models and dif-
ferent disease states based on quantifi able data rather 
than on intuition and argument; thus, it can lead to 
better experimental design and clinical practice. 
 Data thus far support the model concept that the 
component items can vary with some independence. 
An earlier laboratory experiment confi rmed that the 
sensory quality of work/effort can vary independently 
from the sensory quality of air hunger and showed 
that sensory intensity can vary independently from 
immediate unpleasantness. 24 Another laboratory inves-
tigation confi rmed that the MDP is responsive to 
treatment with morphine. 25 The MDP is rooted in 
these fi ndings and the model because it is designed 
to measure sensory and affective dimensions of dys-
pnea while supporting the relative independence of 
these dimensions. The purpose of this study was to 
provide initial reliability and validity estimates of the 
MDP when administered to the same individuals in 
two settings: during an ED visit and at an outpatient 
follow-up visit 4 to 6 weeks later. 
 Figure 1. Intensity and unpleasantness scaling and listing of other 
items. 
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plaints completed the MDP at T1, with 146 complet-
 ing the tool at T2 and 131 at T3. Sixty-eight of these 
subjects completed the MDP again 4 to 6 weeks after 
the ED visit (T4, T5). The majority of individuals 
took between 2 and 5 min to complete the MDP, 
regardless of setting. The sample at T1 was 56% men 
with a mean   SD age of 53   15 years. Most partici-
pants had asthma, COPD, pneumonia, or conges-
tive heart failure ( Table 1 ). The follow-up sample 
at T4 was similar in composition, although slightly 
older (59   14 years) and with more men (62%). The 
entire sample was heterogeneous, encompassing a 
variety of individuals who sought urgent care because 
of breathing diffi culty ( Table 1 ). 
 Factor Analysis and Reliability 
 Exploratory factor analysis identifi ed two factors 
at T1 that explained 66% of total variance in the set 
of items ( Table 2 ). Factor 1 included overall inten-
sity and unpleasantness of breathing along with the 
fi ve sensory quality items and was labeled “immediate 
perception.” Factor 2 comprised all fi ve of the emo-
tion items and was labeled “emotional response.” Factor 
analysis applied to T2 and T3 data identifi ed the same 
two factors with strong ( . 0.66) primary item loadings 
on a single factor at each time point ( Table 2 ). Imme-
diate perception and emotional response remained 
 After informed consent in the ED, we administered the MDP 
(T1), followed by a second administration   60 min later (T2), 
which served as a stability check (test-retest reliability ), with the 
assumption that dyspnea might change but not resolve completely. 
At least 1 h after the second administration, the MDP was com-
pleted a third time (T3) to assess responsiveness to clinical change. 
 The MDP was administered a fourth and fi fth time (T4, T5) 
at follow-up 4 to 6 weeks after discharge, with spirometry, pulse 
oximetry, and additional questionnaire data obtained for construct 
validity testing. Following completion of those additional mea-
sures, the MDP was administered again for the second time in the 
follow-up group (T5) as another stability check. Spirometry testing 
was done using a MicroLoop spirometer (CareFusion Corporation), 
according to guidelines established by the American Thoracic 
Society and European Respiratory Society, 30 using National 
Health and Nutrition Examination Survey III predicted values. 
 Additional questionnaires included the Mini-Mental State 
Examination (MMSE), 31 Brief Symptom Inventory (BSI), 32 the 
modifi ed Pulmonary Function Status Dyspnea Questionnaire 
(PFSDQ-M), 33 and the Medical Research Council (MRC) dysp-
nea scale. 34 The MMSE is a cognitive screening tool with scores 
ranging from 0 to 30; scores of   24 are normal. The BSI uses 
18 items from the Symptom Checklist-90-R, 35 having three sub-
scales (somatization, depression, and anxiety) normed with T scores. 
The PFSDQ-M measures dyspnea and fatigue, with higher scores 
indicating greater intensity. 31 Two items that ask about levels 
on most days and today were used. The MRC estimates dyspnea 
by grading breathing diffi culty with daily activities. 36 Scores 
range from grade 1 to 5, with satisfactory reliability 37 and validity 38 
reported. 
 Analysis 
 Analysis began with exploratory principal components analy-
sis using a varimax rotation, using T1 data to determine the 
underlying factorial structure of the MDP. 39 Details of the factor 
analysis procedures, factor selection, and item retentions are 
available in e-Appendix 1. The same analysis was run with data 
from T2 and T3 to assess the temporal stability of the MDP pro-
posed domain structure. A separate factor analysis was not con-
ducted at T4 because of the substantially smaller sample size. 
 After determining the proposed domain structure of the MDP 
through the factor analysis, 40 we calculated Cronbach  a for each 
domain at each administration and intraclass correlation coef-
fi cients (ICCs) for the domains and individual items across suc-
cessive administrations. ICCs were used for test-retest reliability 
because unlike conventional correlation coeffi cients, ICCs account 
for error variance attributable to discrepancy over time. 41 ICCs 
for domains were calculated using a two-way mixed-model analy-
sis of variance for consistency of average measures and a two-
way mixed model for absolute agreement for single items. 42,43 
Calculation of domain and item ICCs provided support for use 
of the stability of individual items or domains, depending on the 
proposed MDP use. Construct validity was assessed by correla-
tions of the MDP domains with the additional questionnaire, 
spirometry, and pulse oximetry data obtained at T4. We used 
repeated-measures analysis of variance of the MDP domains and 
items using T1, T3, and T4 scores to determine responsiveness to 
change in patient condition. Analyses were conducted using SPSS 
version 18 (SPSS, Inc) statistical software. 
 Results 
 Sample 
 A total of 151 adults with cardiac or respiratory 
disease who came to the ED with breathing com-
 Table 1— Basic Demographic Characteristics of Time 1 
and 4 Samples 
Demographic Characteristic
Time 1 
(n  5 151)
Time 4
(n  5 68)
Age, y 53.2   15.8 58.5   13.5
Male sex 85 (56) 42 (62)
Race
 White 118 (78) 60 (88)
 Black 10 (7) 2 (3)
 Native American 8 (5) 4 (6)
 Other 15 (10) 2 (3)
Ethnicity
 Hispanic 38 (25) 16 (24)
Diagnosis
 Asthma 43 (29) 15 (22)
 COPD 41 (27) 24 (35)
 Congestive heart failure 19 (13) 5 (7)
 Pneumonia 28 (19) 12 (18)
 Other 20 (13) 12 (18)
Spirometry a 
 FEV 1 , L … 2.22   0.94
 FEV 1 % predicted normal value … 70.7 (25.1)
 FVC, L … 2.95   1.10
 FVC % predicted normal value … 73.3 (21.3)
 FEV 1 /FVC … 74.0 (15.6)
Years of education … 13.7   2.9
Number in household … 2.2   1.9
Time to follow-up, wk … 5.6   2.7
Data are presented as mean   SD or No. (%).
 a Sample size dropped to n  5 65.
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strongest correlations found between the BSI anxi-
ety and depression domains and emotional response 
and between BSI somatization and immediate per-
ception ( Table 4 ), supporting the construct validity 
of the two MDP domains. There were no signifi cant 
correlations with spirometry measures, MMSE, BMI, 
or resting pulse oximetry levels for either domain, 
which was consistent with the literature. 45,46 
 Responsiveness 
 The median time from arrival to T1 (enrollment) 
was   6.5 h, and the median time from T1 to T3 
was   2 h. The median time to follow-up (T1-T4) was 
36 days. A signifi cant main effect of time ( F [2,66]    19.67, 
 P  , .001) was identifi ed for the two domain scores of 
the MDP from T1, T3, and T4 ( Fig 2 ). In addition, all 
items were found to have a signifi cant change over 
time. ( F [2,66]    5.51,  P   .01) and suitable individual 
effect sizes ( h 2 , 0.15-0.38) (e-Appendix 1). 
 Discussion 
 The results show that the MDP is internally con-
sistent, has a stable factor structure, and has subject 
ratings that are reliable over time. In the ED, the 
test-retest interval was short to assess stability in an 
acute, rapidly changing clinical setting. Test-retest 
reliability was assessed during the follow-up interval 
as well, with the results again supporting stability. We 
presented evidence of the construct and structural 
validity of the MDP using factor analysis at three dif-
ferent time periods, and of the correlation of the 
MDP with established questionnaires. 
relatively constant, with some variations in the load-
ing across time ( Table 2 ). The total explained vari-
ance was 74% at T2 and 72% at T3, demonstrating 
a stable factor structure across all three time points 
and defi ning two MDP domains. 40,41 These factors 
(underlying dimensions) were labeled “domains” sim-
ilar to the use of this term in the St. George Respi-
ratory Questionnaire. 44 
 The reliability (Cronbach  a and ICC) estimates for 
the immediate perception and emotional response 
domains are shown in  Table 3 . Both domains had a 
Cronbach  a values  . 0.80 at all time points and ICC 
values  . 0.90 for the T1 to T2 and T4 to T5 intervals. 
ICCs for individual items across the same time inter-
vals were acceptable ( . 0.60), with the exception of 
the overall intensity and unpleasantness of breath-
ing items ( Table 3 ). The two domains were summed 
to allow for subscale assessment, but a total sum-
mated score was not calculated. 
 Construct Validity 
 Correlations with other measures at T4 were ana-
lyzed to assess convergent and discriminant valid-
ity of the two MDP domains. There was a signifi cant 
correlation between the self-reported frequency of 
breathlessness per day with the immediate perception 
domain but not with the emotional response domain. 
The MRC correlated approximately equally with 
both MDP domains. Correlations with the PFSDQ-M 
questions of shortness of breath today and fatigue 
today were stronger for MDP immediate perception 
than for emotional response ( Table 4 ). The correla-
tions with BSI domains were signifi cant, with the 
 Table 2— Factor Loadings at Time 1, 2, and 3 
Time 1 (n  5 151) Time 2 (n  5 146) Time 3 (n  5 131)
Factor Factor Factor
Items and Proposed Item Categories Item 1 2 1 2 1 2
My breathing requires muscle 
work or effort
SQ-1 0.840 a 0.306 0.890 a 0.239 0.845 0.239
I am breathing a lot (breathing rapidly, 
deeply, or heavily)
SQ-5 0.839 0.198 0.824 0.324 0.824 0.324
My chest and lungs feel tight or constricted SQ-4 0.805 0.325 0.870 0.244 0.845 0.244
I am not getting enough air, I feel hunger 
for air, or I am smothering
SQ-2 0.793 0.269 0.863 0.308 0.846 0.308
My breathing requires mental effort 
or concentration
SQ-3 0.791 0.204 0.797 0.326 0.805 0.326
Unpleasantness of breathing 0.775 0.254 0.835 0.306 0.874 a 0.306
Intensity of breathing 0.704 0.268 0.804 0.245 0.826 0.245
Angry E-4 0.099 0.826 a 0.162 0.758 0.162 0.758
Frustrated E-3 0.365 0.776 0.285 0.825 a 0.285 0.825 a 
Anxious E-2 0.387 0.692 0.342 0.687 0.342 0.687
Afraid E-5 0.295 0.667 0.352 0.745 0.352 0.745
Depressed E-1 0.183 0.663 0.198 0.732 0.198 0.732
E  5 emotional response (1-5 item instrument order); SQ  5 sensory quality (1-5 item instrument order).
 a Indicates highest loading within factor at each time point.
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of independence between the resultant emotional 
response and the more immediate aspects of dysp-
nea. The study, however, fails to show independence 
between immediate sensory intensity and immediate 
unpleasantness. In these patients in the ED, sensa-
tions of intensity, unpleasantness, and quality were 
grouped together as an immediate experience of 
breathing discomfort. Laboratory studies have sepa-
rated the immediate intensity from immediate unpleas-
antness of dyspnea, but even in these studies, a number 
of individuals found it diffi cult to separate these two 
aspects. 25 The separation of immediate intensity 
from immediate unpleasantness is probably diffi cult 
 In this clinical sample, factor analysis determined 
two domains that explained a substantial total item 
variance and maintained structural validity over time. 
Given that the factor analysis extracted two com-
paratively separate domains, a single total score is 
not appropriate. The results of this analysis support 
the two-domain structure as valid, relatively indepen-
dent, and stable over time. 
 The present conceptual model proposes sepa-
rable components of the dyspnea experience: imme-
diate sensory response, immediate unpleasantness, 
and resultant emotional response . 14 The present 
fac tor analysis results are consistent with a degree 
 Table 3— Reliability Estimates by Items and Subscales Across Time 
ED Follow-up
Subscales/Items T1 (n  5 151) T2 (n  5 146) T3 (n  5 131) T1-T2 T4 (n  5 68) T5 (n  5 68) T4-T5
Immediate perception domain  a  5 0.93  a  5 0.96  a  5 0.96 …  a  5 0.94  a  5 0.97 …
30.6   18.6 24.8   18.8 25.1   18.6 0.96 (96-0.97) 15.7   14.1 13.5   14.8 0.98 (97-0.98)
 Unpleasantness of breathing 5.1   2.6 4.5   2.7 4.4   2.6 0.47 (35-0.58) 3.7   2.5 2.4   2.3 0.67 (53-0.77)
 Intensity of breathing 4.9   2.9 4.0   2.8 4.0   3.7 0.58 (47-0.67) 2.5   2.4 2.1   2.3 0.79 (69-0.86)
 SQ-1 4.4   3.2 3.5   2.1 3.5   3.0 0.73 (64-0.80) 2.2   2.3 1.9   2.3 0.81 (71-0.88)
 SQ-2 3.8   3.3 3.2   3.2 3.4   3.0 0.77 (69-0.83) 1.6   2.1 1.7   2.2 0.86 (78-0.91)
 SQ-3 3.4   3.3 2.9   3.1 2.9   3.0 0.76 (68-0.82) 1.7   2.5 1.9   2.5 0.91 (86-0.95)
 SQ-4 4.5   3.3 3.5   3.2 3.5   3.1 0.76 (69-0.82) 2.2   2.3 1.9   2.3 0.87 (80-0.92)
 SQ-5 4.4   3.4 3.3   3.1 3.0   3.4 0.66 (56-0.75) 1.8   2.2 1.6   2.3 0.83 (74-0.94)
Emotional response domain  a  5 0.84  a  5 0.86  a  5 0.86 …  a  5 0.92  a  5 0.94 …
18.5   13.5 15.4   13.0 13.5   12.3 0.91 (88-0.93) 9.7   11.7 7.7   10.9 0.96 (94-0.97)
 E-1 2.9   3.1 2.4   3.2 1.9   2.7 0.71 (62-0.77) 2.0   2.9 1.6   2.5 0.88 (81-0.92)
 E-2 4.1   3.4 3.5   3.0 3.4   3.1 0.61 (50-0.69) 2.2   2.8 1.6   2.4 0.80 (70-0.86)
 E-3 4.9   3.5 4.0   3.4 3.4   3.2 0.63 (53-0.71) 2.3   2.8 1.9   2.6 0.83 (75-0.89)
 E-4 2.8   3.4 2.2   3.1 1.8   2.9 0.62 (52-0.70) 1.4   2.4 1.3   2.2 0.85 (78-0.90)
 E-5 3.8   3.7 3.4   3.5 3.1   3.4 0.75 (67-0.81) 1.8   2.9 1.3   2.5 0.82 (73-0.88)
Data are presented as Cronbach  a , mean   SD, or intraclass correlation coeffi cient (95% CI). See Figure 1 for description of sensory qualities and 
emotional responses. See Table 2 legend for expansion of abbreviations.
 Table 4— Spirometry, Oximetry, BMI, and Questionnaire Scores and Bivariate Correlations With the Immediate 
Perception and Emotional Response Domains of the MDP at Follow-up 
Correlation With
Other Time 4 Measures Mean   SD Immediate Perception Emotional Response
FEV 1 % predicted (n  5 65) 70.1   25.1  2 0.131 0.027
FVC % predicted (n  5 65) 73.3   21.3  2 0.138  2 0.017
Mini-Mental Status Examination (n  5 65) 28.4   1.9 0.137 0.028
BMI 30.0   6.9  2 0.003 0.069
Resting Sa o 2 94   2.5  2 0.053  2 0.121
Medical Research Council dyspnea scale 2.5   1.3 0.337 a 0.347 a 
PFSDQ-M SOB on most days 4.0   2.5 0.470 a 0.320 a 
PFSDQ-M SOB today 3.1   2.5 0.765 a 0.605 a 
PFSDQ-M fatigue on most days 4.7   2.7 0.571 a 0.473 a 
PFSDQ-M fatigue today 3.6   2.8 0.700 a 0.560 a 
BSI somatization 62.0   11.1 0.551 a 0.451 a 
BSI depression 55.0   11.2 0.535 a 0.572 a 
BSI anxiety 55.6   11.3 0.662 a 0.678 a 
BSI  5 Brief Symptom Inventory T score; MDP  5 Multidimensional Dyspnea Profi le; PFSDQ-M  5 modifi ed Pulmonary Functional Status and 
Dyspnea Questionnaire; Sa o 2  5 arterial oxygen saturation; SOB  5 shortness of breath.
 a Signifi cant at the .01 level.
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 Limitations of this study include the use of a con-
venience sample and the exclusion of patients who 
were too ill to complete self-report measures, who 
did not speak and understand English, and who were 
unwilling to participate in an observational study in 
which there was no expectation of immediate benefi t. 
Even so, the sample size was adequate for conduct-
ing factor analysis (13 subjects per questionnaire 
item compared with 10 subjects per item recom-
mended by Nunnally and Bernstein 39 ). We have 
demonstrated that the MDP is comprehensible to 
a heterogeneous sample of patients with acute and 
chronic cardiopulmonary conditions in both an acute 
care and a stable follow-up setting. 
 There is a need for reliable, valid, and responsive 
patient-reported outcome measures to judge how 
patients are responding to clinical treatments, changes 
in qualities of breathing sensations, and as an end point 
in clinical trials intended to improve breathlessness. 51,52 
Although more testing of the MDP is indicated and 
ongoing, these initial results in a relatively large and 
diagnostically heterogeneous clinical sample suggest 
that the MDP shows promise of being useful in both 
acute care and stable follow-up settings. 
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and responsiveness over time ( Table 3 ) and could 
be used independently to describe changes in qual-
ities or emotions. 
 The two domains of the MDP revealed by the cur-
rent study demonstrated adequate responsiveness 
to change in clinical condition, corresponding to 
nonspecifi c effects of ED and subsequent treatment. 
To our knowledge, this is the fi rst multidimensional 
dyspnea measure that has been used in both an ED 
and a stable outpatient follow-up setting with the 
same subjects. We know of only one other dyspnea 
measure with a similar factor structure, 47-50 but that 
tool proposes a total score, has only been tested in 
outpatients, and, thus far, has not been tested for 
responsiveness to change in condition. 
 Figure 2. Multidimensional Dyspnea Profi le immediate per-
ception and emotional response domain score change at admission 
to the ED (T1), discharge from the ED (T3), and follow-up (T4). 
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